PLX · Protalix BioTherapeutics, Inc.
$2.30
+0.08 (+3.60%)
At close · Aug 17
Market Cap
$178.87M
Shares
80.57M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-30 | 70 | $2.27 | $159 |
| 2026-07-24 | 3 | $2.37 | $7 |
| 2026-07-13 | 33,000 | $2.44 | $80,520 |
| 2026-07-02 | 489 | $2.30 | $1,125 |
| 2026-06-30 | 3,573 | $2.35 | $8,397 |
| 2026-06-18 | 2,992 | $2.02 | $6,044 |
| 2026-06-15 | 1,045 | $2.09 | $2,184 |
| 2026-06-10 | 6,581 | $1.98 | $13,030 |
| 2026-06-08 | 60 | $1.99 | $119 |
Showing 1–9 of 9 settlements
Key facts
CIK
1006281
CUSIP
74365A309
13F (30d)
98 filings
96 filers
Visit website
Investor relations